J. S. Martino

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.

S. Sookoian, T. Gianotti, María Soledad Rosselli, 2010, Atherosclerosis.

Mitochondrial genome architecture in non‐alcoholic fatty liver disease

H. Dopazo, S. Sookoian, T. Gianotti, 2016, The Journal of pathology.

Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease

S. Sookoian, T. Gianotti, A. Burgueño, 2012, Gut.

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease

H. Dopazo, S. Sookoian, T. Gianotti, 2015, Medicine.

Leiomiosarcoma infiltrante en la lengua

Luis Sarra, L. Gonzalez Roma, M. Nicita, 2010 .

Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease

S. Sookoian, G. Castaño, C. Pirola, 2018, Scientific Reports.

Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease

S. Sookoian, T. Gianotti, A. Burgueño, 2012, Gut.